After signing up, you'll start to receive regular news updates from us.
GeneLink Receives US Patent for DNA-Based Skin Health Assessment
Complete the form below to unlock access to ALL audio articles.
GeneLink, Inc. has announced that the Unites States Patent Office issued GeneLink a patent for its proprietary method for assessing skin health in humans.
U.S. Patent number 7,211,383, entitled "KITS AND METHODS FOR ASSESSING SKIN HEALTH." was granted on May 1, 2007. This is the latest patent to be granted from a family of patent applications filed by GeneLink in the US and abroad.
GeneLink’s Skin Health Assessment is a DNA-based test used to genetically predict an individual’s risk for a variety of age-associated skin conditions including: premature aging due to excessive oxidative stress, collagen breakdown, photo aging and the skin’s ability to tolerate environmental pollutants.
“The granting of this patent further confirms GeneLink's confidence in its ongoing research and the commercial potential of its technology,” says Monte Taylor, Jr., GeneLink’s CEO. “Just as important, GeneLink is continuing to develop 'genetically guided product solutions' to help consumers reduce or prevent the risks measured by GeneLink’s tests.”
Based on the analysis of key genes, GeneLink’s DNA tests provide information that enables the customization of skin-care products, nutritional products, and health maintenance regimens that can be personalized to meet individual consumer’s need.
